Dr. Anita Finnegan is the Founder and CEO of Nova Leah, a world leader in the provision of cybersecurity risk management solutions for connected medical devices. SelectEvidence® from Nova Leah is the first risk management tool in the world to deliver medical device compliance across multiple international standards. Anita is a global expert in cybersecurity for medical devices. She has authored two internationally regulated industry standards for medical equipment – ISO/IEC 80001-2-8 and ISO/IEC 80001-2-8.
Through her work with Nova Leah, Finnegan has won multiple awards for innovation, security and technological impact. Nova Leah was named Emerging Company of Year at the 2019 Technology Ireland Awards in association with Ibec and was runner-up by Digital Europe for the European ‘Future Unicorn Award’ in 2020. Most recently, Dr Finnegan was named as a finalist in the EU Women Innovator Prize and won the 2021 Science Foundation Ireland (SFI) Entrepreneurship Award. Nova Leah was featured in WIRED Magazine as one of ‘Europe’s 100 Hottest Startups’ and Finnegan was listed in ‘50 Female Entrepreneurs Everyone Should Know’ by Crunchbase. As a global cybersecurity authority, Dr Finnegan acts as an advisor to a number of government bodies.